160 related articles for article (PubMed ID: 23377187)
21. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells inhibit hepatitis C virus expression.
Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
[TBL] [Abstract][Full Text] [Related]
23. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
24. 4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents.
Shakya N; Vedi S; Liang C; Yang F; Agrawal B; Kumar R
Bioorg Med Chem Lett; 2014 Mar; 24(5):1407-9. PubMed ID: 24485784
[TBL] [Abstract][Full Text] [Related]
25. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
[TBL] [Abstract][Full Text] [Related]
26. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
29. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
[TBL] [Abstract][Full Text] [Related]
30. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
32. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of hepatitis C virus replication by antimonial compounds.
Hwang DR; Lin RK; Leu GZ; Lin TY; Lien TW; Yu MC; Yeh CT; Hsu JT
Antimicrob Agents Chemother; 2005 Oct; 49(10):4197-202. PubMed ID: 16189098
[TBL] [Abstract][Full Text] [Related]
34. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
[TBL] [Abstract][Full Text] [Related]
35. Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression.
Tseng CH; Lin CK; Chen YL; Tseng CK; Lee JY; Lee JC
Eur J Med Chem; 2018 Jan; 143():970-982. PubMed ID: 29232587
[TBL] [Abstract][Full Text] [Related]
36. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
37. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
38. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HCV evaluation of 4'(alpha)-ethyl and 2'(beta)-methyl-carbodine analogues.
Li H; Yoo JC; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Sep; 28(9):809-20. PubMed ID: 20183620
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hepatitis C virus replication by arsenic trioxide.
Hwang DR; Tsai YC; Lee JC; Huang KK; Lin RK; Ho CH; Chiou JM; Lin YT; Hsu JT; Yeh CT
Antimicrob Agents Chemother; 2004 Aug; 48(8):2876-82. PubMed ID: 15273095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
